Pfizer, BioNTech to supply COVID-19 vaccines for Olympic athletes

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

BRUSSELS: US drugs giant Pfizer and its German partner BioNTech on Thursday (May 6) announced a deal with the International Olympics Committee to ...

BRUSSELS: US drugs giant Pfizer and its German partner BioNTech on Thursday announced a deal with the International Olympics Committee to provide vaccines to competitors and staff members at the Tokyo games.

The agreement was welcomed by IOC president Thomas Bach, who has already seen the Tokyo Games postponed from last year because of the pandemic. The IOC has been promising for months that the Olympics would be safe even without widespread vaccination, thanks to a battery of health precautions.But the agreement with Pfizer is seen as important as Tokyo and several Japanese regions are once again under a state of alert due to the increase in cases of COVID-19, amid lingering doubts about the wisdom of holding the games.

In an attempt to appease the scepticism of the Japanese public, organisers last week tightened the anti-virus measures imposed on both Olympic delegations and the media.Albert Bourla, chairman and CEO of Pfizer and Ugur Sahin or BioNTech said their firms were proud to supply the vaccine - already the mainstay of Europe's inoculation effort - to the Games.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

South Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shotOne dose of COVID-19 vaccines from AstraZeneca Plc and Pfizer was 86.6% effective in preventing infections among people aged 60 and older, real world data released by South Korea showed on Wednesday. Data by the Korea Disease Control and Prevention Agency (KDCA) showed the Pfizer vaccine, jointly developed by BioNTech, was 89.7% effective in preventing infection at least two weeks after a first dose was given, while the AstraZeneca shot was 86.0% effective. Its analysis is based on more than 3.5 million people in South Korea aged 60 and older for two months from Feb. 26 and included 521,133 people who received a first dose of either Pfizer or AstraZeneca shot.
Source: YahooSG - 🏆 3. / 71 Read more »

US authorises Pfizer/BioNTech Covid-19 vaccine for children 12 to 15
Source: TODAYonline - 🏆 1. / 99 Read more »

Pfizer sees Covid-19 as 'durable' revenue stream as profits riseNEW YORK — Pfizer sharply increased its 2021 profit projections on Tuesday (May 4), citing much higher Covid-19 vaccine sales which are on track to provide a They are in it just for profits. A corrupt entity that puts profits ahead of human lives. This virus is a false flag operation
Source: TODAYonline - 🏆 1. / 99 Read more »

Canada authorises Pfizer Covid-19 vaccine for kids age 12 and up
Source: TODAYonline - 🏆 1. / 99 Read more »

South Korea says AstraZeneca, Pfizer COVID-19 vaccines 87% effective after first shotSEOUL: One dose of COVID-19 vaccines from AstraZeneca and Pfizer was 86.6 per cent effective in preventing infections among people aged 60 and ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Pfizer sees robust COVID-19 vaccine demand for years, US$26 billion in 2021 salesPfizer on Tuesday (May 4) raised its forecast for 2021 COVID-19 vaccine sales by more than 70 per cent to US$26 billion and said demand from ... 輝瑞疫苗賺大錢了!
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »